newsfilter
← Latest News
Business Wire·

Natera to Support New Clinical Trial Assessing ctDNA Dynamics with Latitude™ in Advanced Skin Cancers

Phase I trial in Germany will support treatment response monitoring for Kupando Therapeutics’ investigational immunotherapy using Latitude MRD testing Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and